Actively Recruiting
Understanding Androgen Excess and Metabolic Problems in Women with Polycystic Ovary Syndrome Using Detailed Body and Blood Analysis
Led by Imperial College London · Updated on 2024-12-05
1000
Participants Needed
1
Research Sites
47 weeks
Total Duration
AI-Summary
What this Trial Is About
Polycystic ovary syndrome PCOS affects about 10% of women and is characterized by irregular periods and fertility challenges. It is also a lifelong metabolic disorder linked to higher risks of type 2 diabetes, high blood pressure, and heart disease. This study aims to identify subsets of women with PCOS who are at the highest risk of developing metabolic diseases by assessing their clinical signs, androgen levels, and metabolic function using detailed phenome and metabolome data.
CONDITIONS
Brief Title
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
Research Team
E
Eka Melson
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
